Novel S1P-Receptor Modulator Shows Promise in Phase 2b AD Trial Novel S1P-Receptor Modulator Shows Promise in Phase 2b AD Trial

' This was a short proof-of-concept study to show this mechanism is valid. The results are promising, ' said Dr Emma Guttman-Yassky, who presented the study at the American Academy of Dermatology meeting.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news